MARSHALL MEDICAL CENTERS SOUTH
1. Target Overview & Investment Thesis
MARSHALL MEDICAL CENTERS SOUTH is a 178-bed safety-net/medicaid heavy in MARSHALL, AL with $186.9M in net patient revenue and a -6.3% operating margin. The hospital serves a payer mix of 26.1% Medicare, 23.7% Medicaid, and 50.2% commercial.
Thesis: Undervalued. Our ML models identify $13.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.3% to 1.0% (+736bps).
| Net Revenue HCRIS | $186.9M |
| Current EBITDA COMPUTED | $-11.9M |
| Operating Margin COMPUTED | -6.3% |
| Occupancy HCRIS | 54.6% |
| Revenue / Bed COMPUTED | $1.0M |
| Net-to-Gross HCRIS | 35.9% |
| Distress Probability ML | 53.0% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -6.3% places it above the state median. Among 36 size-comparable peers (89-356 beds), the median margin is -4.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (89-356), prioritizing same-state peers. 36 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MARSHALL MEDICAL CENTERS SOUTH (Target) | AL | 178 | $186.9M | -6.3% |
| THE CHILDRENS HOSPITAL OF ALAB | AL | 351 | $839.5M | 5.8% |
| BAPTIST MEDICAL CENTER SOUTH | AL | 348 | $595.4M | -4.8% |
| SOUTHEAST HEALTH MEDICAL CENTE | AL | 353 | $427.1M | -4.4% |
| EAST ALABAMA MEDICAL CENTER | AL | 297 | $399.6M | -6.5% |
| USA HEALTH UNIVERSITY HOSPITAL | AL | 242 | $348.5M | -6.4% |
| JACKSON HOSPITAL AND CLINIC I | AL | 278 | $301.4M | -10.4% |
| NORTH ALABAMA MEDICAL CENTER | AL | 223 | $259.5M | 0.5% |
| CRESTWOOD MEDICAL CENTER | AL | 164 | $258.9M | 14.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $13.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $120K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-11.9M |
| + RCM Uplift | +$13.8M |
| Pro Forma EBITDA | $1.9M |
| Current Margin | -6.3% |
| Pro Forma Margin | 1.0% |
| WC Released (1x) | $7.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-18.2M | $59.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-18.2M | $59.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-16.4M | $98.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-16.4M | $103.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-20.1M | $-3.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-20.1M | $-10.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (23.7%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 53.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 36 hospitals with 89-356 beds
- Same-state prioritization (n=37)
- Comp margins: P25=-10.0% / P50=-4.1% / P75=3.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.